Armstrong, Fleming & Moore, Inc Bristol Myers Squibb CO Transaction History
Armstrong, Fleming & Moore, Inc
- $184 Billion
- Q2 2025
A detailed history of Armstrong, Fleming & Moore, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Armstrong, Fleming & Moore, Inc holds 8,064 shares of BMY stock, worth $369,734. This represents 0.2% of its overall portfolio holdings.
Number of Shares
8,064Holding current value
$369,734% of portfolio
0.2%Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,716Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.78 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.27 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.95 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.35 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...